SPARC to Sell Priority Review Voucher for $195 Million to Support Pipeline Expansion MM Desk 4 May, 2026 Sun Pharma Advanced Research Company Ltd (SPARC) has announced that it has entered into a Read More
SPARC Receives Rare Pediatric Disease Priority Review Voucher Linked to FDA Approval of Sezaby® MM Desk 4 February, 2026 Sun Pharma Advanced Research Company Ltd(SPARC) has announced that the United StatesFood and Drug Administration Read More